Abstract |
The aplyronines are a family of highly cytotoxic marine natural products with potential application in targeted cancer chemotherapy. To address the severe supply issue, function-oriented molecular editing of their macrolactone scaffold led to the design of a series of simplified aplyronine analogues. Enabled by a highly convergent aldol-based route, the total synthesis of four analogues was achieved, with a significant improvement in step economy versus previous compounds, and their cancer cell growth inhibition in the HeLa cell line was determined. The modular strategy presented offers a means for significantly shortening their chemical synthesis to facilitate the continued development of this promising class of anticancer agent.
|
Authors | Talia R Pettigrew, Rachel J Porter, Stephen J Walsh, Michael P Housden, Nelson Y S Lam, Jason S Carroll, Jeremy S Parker, David R Spring, Ian Paterson |
Journal | Chemical communications (Cambridge, England)
(Chem Commun (Camb))
Vol. 56
Issue 10
Pg. 1529-1532
(Feb 04 2020)
ISSN: 1364-548X [Electronic] England |
PMID | 31922172
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Macrolides
- aplyronine C
- aplyronine D
- aplyronine A
|
Topics |
- Antineoplastic Agents
(chemical synthesis)
- Cell Proliferation
(drug effects)
- HeLa Cells
- Humans
- Macrolides
(chemistry, pharmacology)
- Molecular Conformation
- Stereoisomerism
- Structure-Activity Relationship
|